A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort (NCT06492174)
AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the AGENT IDE study is to assess the safety and effectiveness of the Agent Paclitaxel Coated PTCA Balloon Catheter in patients with in-stent restenosis (ISR) of a previously treated lesion of up to 36 mm in length (by visual estimate) in a native coronary artery 2.0 mm to 4.0 mm in diameter.
Who can join: Review the eligibility criteria below.
Location: Carondelet Medical Group St. Mary's Hospital — Tucson, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Carondelet Medical Group St. Mary's Hospital — Tucson, Arizona
- Cedars Sinai Medical Center — Los Angeles, California
- Emory University Hospital — Atlanta, Georgia
- Henry Ford Hospital — Detroit, Michigan
- Columbia University Medical Center — New York, New York
- St. Francis Hospital — Roslyn, New York
- Lindner Center for Research and Education at Christ Hospital — Cincinnati, Ohio
- UPMC Pinnacle Health — Wormleysburg, Pennsylvania
- Rhode Island Hospital — Providence, Rhode Island
- Centennial Medical Center — Nashville, Tennessee
- Baylor Heart and Vascular Hospital — Dallas, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in In-Stent Restenosis
Explore by condition: All In-Stent Restenosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.